Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

This study is a cross-sectional survey-based study. The main goal of this study is to investigate the attitudes, perceptions, and clinical practice in assessing liver fibrosis following a metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosis, and the management of MASLD patients among Chinese physicians in the departments of endocrinology / hepatology / infection / gastroenterology in Grade IIIA hospitals in provincial capitals or municipalities.

NCT Number	NCT07682363
Lead Sponsor	Novo Nordisk A/S
Conditions	Liver Disease
Enrollment	470 participants
Start Date	2026-06-03
Primary Completion	2027-02-23 (estimated)
Study Completion	2027-02-23 (estimated)
Updated on ClinicalTrials.gov	2026-07-02